Last reviewed · How we verify
Salonsip plaster
Salonsip is a transdermal plaster that delivers salicylic acid and other active ingredients through the skin to provide localized pain relief and anti-inflammatory effects.
Salonsip is a transdermal plaster that delivers salicylic acid and other active ingredients through the skin to provide localized pain relief and anti-inflammatory effects. Used for Localized musculoskeletal pain and inflammation.
At a glance
| Generic name | Salonsip plaster |
|---|---|
| Sponsor | Hisamitsu Farmaceutica do Brasil Ltda |
| Drug class | Topical analgesic/anti-inflammatory plaster |
| Modality | Small molecule |
| Therapeutic area | Pain Management / Musculoskeletal Disorders |
| Phase | Phase 3 |
Mechanism of action
As a topical plaster formulation, Salonsip works by penetrating the skin barrier to deliver its active pharmaceutical ingredients directly to affected tissues. The formulation is designed to provide sustained, localized therapeutic effects for musculoskeletal pain and inflammation without systemic absorption.
Approved indications
- Localized musculoskeletal pain and inflammation
Common side effects
- Skin irritation at application site
- Contact dermatitis
- Erythema
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Salonsip plaster CI brief — competitive landscape report
- Salonsip plaster updates RSS · CI watch RSS
- Hisamitsu Farmaceutica do Brasil Ltda portfolio CI